Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma.
Jialei WengChenhao ZhouQiang ZhouWanyong ChenYirui YinManar AtyahQiongzhu DongYi ShiNing RenPublished in: Journal of hepatocellular carcinoma (2021)
We developed a prognostic signature based on 10 metabolic genes, which has proven to be an independent and reliable prognostic predictor for HCC and reflects the metabolic and immune characteristics of tumors.